费城办事处，2021 年 9 月 15 日讯：嘉因生物 Exegenesis Bio 是一家快速发展的全球基因治疗公司，致力于开发针对眼科、中枢神经系统和肝脏疾病的创新基因药物，在此很高兴地宣布任命 Mahen Gundecha 为首席商务官。点击这里读取完整的新闻稿
PHILADELPHIA, PA, September 15, 2021 (BUSINESS WIRE) – Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce the appointment of Mahen Gundecha as Chief Business Officer. Read full press release